🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An exploratory, open-labeled study of participants with Pompe disease, who ...
Status
Terminated
Location
Multiple Locations
Start Date
2008-12-14
Trial ID
NCT00701701
Treatments Being Tested
The objective of this study was to evaluate the efficacy and safety of trea...
Status
Terminated
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01526785
Treatments Being Tested
This Phase I/II open-label, randomized, dose-escalation study will assess t...
Status
Terminated
Location
University of California, Irvine
Start Date
2017-06-21
Trial ID
NCT02898753
Pompe disease (also known as glycogen storage disease Type II) is a rare au...
Status
Completed
Location
Multiple Locations
Start Date
2008-08-26
Trial ID
NCT00486889
Treatments Being Tested
The purpose of this study was to evaluate the efficacy, clinical benefits a...
Status
Completed
Location
Kosair Children's Hospital
Start Date
2009-10
Trial ID
NCT00701129
Treatments Being Tested
This is an open-label, multicenter study of participants with late-onset Po...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01288027
Treatments Being Tested
Primary objective: To obtain data pertaining to the safety and tolerabilit...
Status
Completed
Location
Investigational Site Italy
Start Date
2021-10-14
Trial ID
NCT05073783
This is a multi-stage, phase 2, open-label, multicenter, multinational, asc...
Status
Active Not Recruiting
Location
Regional Medical Genetics Center of New York Site Number : 8400002
Start Date
2017-10-12
Trial ID
NCT03019406
Treatments Being Tested
To describe severe late onset patients with pompe disease receiving Myozyme...
Status
Completed
Location
Pitie-Salpetriere Hospital
Start Date
2007-03
Trial ID
NCT00731081